MINNEAPOLIS, MN, US, Aug. 07, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW), a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, will hold a conference call on Thursday, August 14, 2025 at 5:00 p.m. Eastern time to discuss results for the fiscal first quarter ended June 30, 2025. The financial results will be issued in a press release prior to the call.
Related Questions
How will the Q1 2026 earnings compare to consensus analyst estimates?
What forward-looking statements were made regarding future product launches or market expansion?
What is the company's cash position and runway after the quarter?
Did the company provide guidance for the rest of fiscal 2026, and how does it compare to prior guidance?
What are the key drivers behind any revenue or earnings surprises?
What revenue growth rates and margins did the company report for the quarter?
What are the implications of the earnings results for upcoming FDA or regulatory approvals?
How does PetVivo's valuation metrics (P/E, EV/EBITDA) compare to peers in the veterinary biotech sector?
Are there any notable changes in the company's capital structure, debt, or equity financing discussed?
How did the company's product pipeline progress impact the results?
Will the earnings release trigger any significant share price volatility?
Did the company announce any significant partnerships, acquisitions, or divestitures?